Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Mehmet Arif ICER | Health Professions | Young Scientist Award

Published on by Shen Awards

Assist. Prof. Dr. Mehmet Arif ICER | Health Professions | Young Scientist Award

Assistant Professor Doctor from Amasya University, Turkey

Dr. Mehmet Arif İÇER is an Assistant Professor and Head of the Department of Nutrition and Dietetics at Amasya University, Turkey. With a robust academic and research background, he has rapidly ascended into leadership roles within academia, also serving as the Vice Dean of the Faculty of Health Sciences. His academic journey is marked by excellence in nutrition science, with a particular focus on clinical nutrition, nutritional biomarkers, and metabolic health. Dr. İÇER’s research portfolio includes over 28 peer-reviewed articles published in internationally recognized journals, and his work is widely cited, earning him a position among Stanford’s Top 2% Scientists in 2024. He is actively engaged in both teaching and research, contributing to the academic community through book chapters, conference presentations, and interdisciplinary collaborations. His contributions to science have earned him not only national recognition but also growing international attention. Dr. İÇER is known for his deep interest in biochemistry, dietetics, and evidence-based clinical nutrition. His dedication to public health, teaching, and academic excellence makes him a well-rounded and highly respected young scientist in his field. His role as an academic leader and researcher exemplifies a balanced and progressive academic career in health sciences.

Professional Profile

Education

Dr. Mehmet Arif İÇER holds a comprehensive academic background in the field of Nutrition and Dietetics. He completed his Ph.D. at Gazi University in Ankara, Turkey, between 2018 and 2022, where he focused on evaluating the effects of omega-3 supplementation on serum fetuin-A levels in coronary artery disease—an important contribution to cardiovascular nutrition science. His Master of Science degree, also from Gazi University (2016–2018), examined urinary osteopontin levels and nutritional status in patients with kidney stones. These research endeavors demonstrate his early commitment to investigating nutritional biomarkers and clinical outcomes. Dr. İÇER earned his Bachelor of Science in Nutrition and Dietetics from Erciyes University, Kayseri (2009–2014). During his undergraduate studies, he also participated in the Erasmus exchange program at Semmelweis University in Budapest, Hungary, where he gained valuable international academic exposure. His educational trajectory illustrates a strong foundation in evidence-based nutrition science, combining both theoretical knowledge and clinical application. Each academic step has reinforced his expertise in clinical biochemistry, dietetics, and metabolic health. The depth and continuity of his educational background have been instrumental in shaping his current research focus, academic leadership, and instructional responsibilities at Amasya University.

Professional Experience

Dr. Mehmet Arif İÇER has a well-rounded professional career marked by both academic and administrative roles. He began as a Research Assistant at Amasya University in 2014–2015 before moving to Gazi University, where he continued in the same capacity from 2015 to 2022. During this period, he was actively involved in academic teaching, student mentorship, and collaborative research projects that spanned nutrition therapy, dietary biomarkers, and public health. His dedication and expertise earned him a faculty position as Assistant Professor at Amasya University in 2022. He quickly rose to become the Head of the Department of Nutrition and Dietetics and subsequently the Vice Dean of the Faculty of Health Sciences in 2023. These leadership roles reflect his exceptional organizational skills, administrative competence, and ability to drive academic programs forward. Dr. İÇER’s career is characterized by a dual focus on teaching and research, with a strong emphasis on advancing the quality of nutrition education and fostering interdisciplinary collaboration. His experience working in diverse institutional environments, both as a researcher and as an academic leader, positions him as a dynamic professional with the ability to influence health sciences education and research at both national and international levels.

Research Interests

Dr. Mehmet Arif İÇER’s research interests are deeply rooted in the intersection of clinical nutrition, biochemistry, and public health. He focuses on the role of dietary components and nutritional status in chronic diseases such as coronary artery disease, kidney stones, diabetes, and metabolic syndrome. His doctoral research on the impact of omega-3 fatty acids on serum fetuin-A levels highlights his interest in identifying novel biomarkers for disease diagnosis and management. He is also deeply engaged in studies exploring the relationships between diet quality, food neophobia, orthorexia nervosa, and nutritional adequacy. Another significant area of interest includes gut-brain axis modulation via dietary lipids and the implications of antioxidant dietary indexes. Dr. İÇER has contributed to the understanding of how food and nutritional habits, influenced by sociocultural factors, affect metabolic and cardiovascular health. His interdisciplinary approach often integrates elements from genomics, nutritional epidemiology, and behavioral science, aiming to provide comprehensive insights into how diet impacts health. Through collaborations, book chapters, and conference presentations, he extends his expertise to issues such as fermented foods, food labeling, and religious influences on diet. His research is both practical and innovative, targeting real-world health issues with scientific rigor.

Research Skills

Dr. Mehmet Arif İÇER possesses a diverse and advanced set of research skills critical to the field of health and nutrition sciences. His expertise spans clinical trial design, nutritional assessment, biomarker evaluation, and biochemical laboratory analysis. With strong grounding in medical nutrition therapy and clinical biochemistry, he is well-versed in analyzing how dietary interventions affect physiological markers, such as serum fetuin-A and urinary osteopontin. He demonstrates significant ability in scientific writing and interpretation of statistical data, with nearly 30 peer-reviewed publications to his name. His skills in SPSS, research methodology, and critical review enable him to evaluate both clinical and population-level health outcomes effectively. Dr. İÇER also excels in presenting research findings through scientific posters, oral presentations, and lectures. His technical proficiency extends to Microsoft Office tools, with excellent command of Word, Excel, PowerPoint, and Outlook for academic and administrative use. Furthermore, he maintains a strong knowledge base in current health technologies and is continuously updating his research toolkit. His ability to work collaboratively across disciplines and communicate scientific knowledge effectively has contributed to his success in academia. These skills make him a valuable contributor to ongoing advancements in nutrition and health research.

Awards and Honors

Dr. Mehmet Arif İÇER has received significant recognition for his scholarly contributions, the most prominent being his inclusion in the Stanford University Top 2% Scientists List in 2024, an honor that acknowledges his impactful scientific output and citation record. With a total of 980 citations and an h-index of 11, his work demonstrates both quantity and quality in terms of scientific contributions. His publications in respected international journals such as Journal of Clinical Medicine, Food Science & Nutrition, and International Journal of Environmental Health Research further attest to his academic excellence. Dr. İÇER has also contributed several book chapters and presented at numerous national and international scientific conferences. His early involvement in scientific discourse through poster and oral presentations reflects his long-standing commitment to advancing knowledge in dietetics and health sciences. His academic accolades and growing influence underscore his role as a young leader in nutrition science. In recognition of his leadership, he has also been appointed as the Head of Department and Vice Dean at Amasya University. These distinctions not only honor his academic accomplishments but also signal his potential to make enduring contributions to the field of nutrition and public health.

Conclusion

Dr. Mehmet Arif İÇER exemplifies the qualities of an outstanding young academic and researcher in the field of nutrition and health sciences. His career trajectory, from an early-stage researcher to an academic leader, reflects dedication, scholarly rigor, and a strong commitment to improving public health through science. His research contributions span critical areas such as dietary biomarkers, nutritional status, and disease prevention, aligning with global health priorities. With a well-documented record of peer-reviewed publications, international recognition, and teaching experience, Dr. İÇER has carved out a niche as a thought leader in clinical and community nutrition. His administrative roles further demonstrate his leadership abilities and vision for academic excellence. As a recipient of global recognition, including Stanford’s Top 2% Scientists listing, he stands out as a highly promising candidate for any academic or scientific distinction. Dr. İÇER’s dynamic engagement with research, education, and academic service positions him as a role model for emerging scholars in the health sciences. His continued commitment to interdisciplinary research, international collaboration, and innovation will undoubtedly contribute significantly to advancing both science and public well-being.

Publications Top Notes

  1. Title: Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis
    Journal: Journal of Clinical Medicine
    Year: 2025
    Authors: Duygu Agagündüz, Menşure Nur Çelik, Burcu Deniz Güneş, Büşra Atabilen, Buse Sarıkaya, Mehmet Arif İçer, Ferenc Budán
  2. Title: Association of physical activity status with dietary energy density and nutritional adequacy
    Journal: Food Science and Technology (Brazil)
    Year: 2022
    Authors: Yesildemir, O.; Gencer Bingol, F.; Içer, M.A.; Koksal, E.
  3. Title: Effects of fetuin-A with diverse functions and multiple mechanisms on human health
    Journal: Clinical Biochemistry
    Year: 2021
    Authors: İçer, M.A.; Yıldıran, H.
  4. Title: Effects of vitamin E on neurodegenerative diseases: An update
    Journal: Acta Neurobiologiae Experimentalis
    Year: 2021
    Authors: İçer, M.A.; Arslan, N.; Gezmen-Karadag, M.
  5. Title: Effects of nutritional status on serum fetuin-A level
    Journal: Critical Reviews in Food Science and Nutrition
    Year: 2020
    Authors: İçer, M.A.; Yıldıran, H.
  6. Title: Response to the letter to the editor: Urine osteopontin: A biomarker for diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  7. Title: The potential effects of dietary food and beverage intakes on the risk of kidney stone formation
    Journal: Revista de Nutrição
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.
  8. Title: Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  9. Title: The multiple functions and mechanisms of osteopontin
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.

Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Young Un Choi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Young Un Choi | Medicine and Dentistry | Best Researcher Award

Assistant Professor from WonJu Severance Christian Hospital, South Korea

Dr. Young Un Choi is a highly experienced Clinical Assistant Professor at Yonsei University Wonju College of Medicine, specializing in trauma surgery, emergency medicine, and critical care. Throughout his distinguished medical career, Dr. Choi has been committed to advancing trauma management and emergency surgical procedures through both clinical practice and academic research. He has accumulated extensive hands-on experience working in various hospitals, including service in international medical cooperation programs. His clinical expertise is complemented by his active engagement in numerous national and international trauma, surgery, and emergency care societies. Dr. Choi has published extensively in peer-reviewed journals, contributing significantly to the understanding of trauma mechanisms, surgical interventions, and critical care outcomes. His dedication to continuous learning is evident through his participation in globally recognized trauma certification courses and advanced surgical training programs. Dr. Choi’s research has had a positive impact on the development of trauma care protocols in South Korea, particularly in the establishment and improvement of regional trauma centers. His work addresses critical healthcare challenges, aiming to reduce mortality rates and improve the survival and recovery of severely injured patients. With a solid foundation in clinical excellence, academic rigor, and a vision for improving trauma systems, Dr. Choi stands out as a leading contributor in his field.

Professional Profile

Education

Dr. Young Un Choi has pursued a comprehensive medical education that forms the foundation of his clinical and research expertise. He began his medical studies at Inje University College of Medicine from March 2000 to February 2008, where he earned his medical degree. Demonstrating a strong interest in further specialization, he pursued a Master’s degree at the same institution from March 2011 to February 2017, focusing on advanced surgical practices and trauma management. His academic journey continued with a Ph.D. from Yonsei University Wonju College of Medicine, which he completed between March 2019 and February 2022. This doctoral program allowed him to delve deeply into the field of trauma surgery, focusing on the complex interrelationships between surgical techniques, patient outcomes, and trauma care systems. Throughout his academic development, Dr. Choi consistently balanced clinical responsibilities with advanced studies, equipping him with both theoretical knowledge and practical proficiency. His educational progression reflects a deliberate effort to strengthen his expertise in emergency medicine and critical care, positioning him to contribute meaningful advancements in these domains. The combination of medical, master’s, and doctoral degrees underscores his commitment to lifelong learning and clinical excellence, ultimately shaping him into a highly skilled and knowledgeable leader in trauma and critical care research.

Professional Experience

Dr. Young Un Choi has built an impressive career with extensive professional experience across multiple clinical and academic roles. He began his journey in 2008 as an intern doctor at Good Samsun Hospital, followed by residency training in surgery at Inje University Ilsan Paik Hospital from 2009 to 2013. His early focus on pediatric surgery led him to a short-term observer fellowship at Samsung Medical Center in 2013. From 2013 to 2015, he served as a clinical instructor in surgery at Inje University Ilsan Paik Hospital. His international exposure includes working as a medical doctor for the Korea International Cooperation Agency at the Korean-Laos Children’s Hospital between 2015 and 2016, contributing to global medical aid. In 2016, Dr. Choi joined Yonsei University as a Clinical Research Assistant Professor in trauma and intensive care, advancing through academic ranks to his current role as Clinical Associate Professor at Wonju Severance Christian Hospital. His career is marked by consistent growth in trauma surgery and critical care, and he has played a crucial role in clinical education and the development of trauma systems. His professional timeline showcases a dynamic balance between clinical excellence, academic service, and humanitarian medical missions.

Research Interest

Dr. Young Un Choi’s primary research interests focus on trauma surgery, emergency medicine, critical care management, and surgical outcomes in severely injured patients. His work consistently addresses challenges in managing complex trauma cases, particularly blunt abdominal and chest injuries, as well as the evaluation and optimization of diagnostic and surgical interventions. Dr. Choi is especially interested in improving the early identification of critical injuries, developing efficient trauma assessment methods, and refining surgical protocols to reduce mortality and complication rates. He has a strong focus on the utilization of radiographic techniques in trauma diagnosis, the prevention and management of surgical site infections, and strategies for enhancing survival in patients with severe polytrauma. Additionally, his research covers postoperative critical care and the role of advanced therapies such as immunoglobulin administration and antithrombin III in trauma patients. Dr. Choi also explores trauma care efficiency during mass gatherings and pandemics, as reflected in his study of trauma center responses during the COVID-19 outbreak. His body of research contributes to the global effort to improve trauma systems, optimize critical care practices, and develop evidence-based guidelines that can be applied both regionally and internationally.

Research Skills

Dr. Young Un Choi possesses a comprehensive skill set in trauma surgery, emergency procedures, critical care, and clinical research methodologies. He is proficient in advanced trauma life support (ATLS), emergency surgical techniques, preperitoneal pelvic packing, and hemodynamic stabilization strategies for severely injured patients. Dr. Choi is highly skilled in utilizing diagnostic tools such as chest radiography and computed tomography in emergency trauma settings, allowing for rapid and accurate injury assessment. His clinical expertise extends to the management of complex abdominal and thoracic injuries, as well as the application of advanced resuscitation protocols in critical care. In addition to his clinical abilities, Dr. Choi is adept at conducting retrospective and prospective clinical studies, employing data analysis, outcome measurement, and cohort study designs to derive meaningful conclusions from patient cases. His proficiency in multi-disciplinary trauma care and his ability to integrate research into clinical practice are evident throughout his published work. Furthermore, he has strong teaching and mentorship skills, regularly contributing to academic activities, surgical training, and national trauma courses. Dr. Choi’s unique combination of hands-on surgical skills, trauma management expertise, and rigorous clinical research make him a valuable contributor to both academic and hospital settings.

Awards and Honors

Dr. Young Un Choi’s distinguished career is supported by several certifications, memberships, and recognitions in the field of trauma and emergency medicine. He holds board certifications in general surgery, trauma surgery, critical care medicine, and emergency trauma surgery, reflecting his multi-specialty proficiency. Dr. Choi has completed numerous internationally recognized training programs, including Advanced Trauma Life Support (ATLS) from Sunnybrook Health Sciences Centre in Canada and the Definitive Surgical Trauma Care (DSTC) course in Sydney, Australia. He is certified in specialized courses such as Advanced Trauma Operative Management (ATOM) and Korean Advanced Life Support (KALS), among others. Dr. Choi is an active member of several professional societies, including the Korean Surgical Society, the Korean Society of Acute Care Surgery, the Korean Society of Traumatology, and the Korean Society of Critical Care Medicine. His involvement in these organizations signifies his dedication to continuous professional development and knowledge dissemination. In addition to his certifications and society memberships, Dr. Choi has served as an instructor for several national trauma training courses, playing a vital role in the education and training of upcoming trauma surgeons and emergency care providers. His honors and certifications underscore his expertise and leadership in the trauma field.

Conclusion

Dr. Young Un Choi is a dedicated and highly skilled trauma surgeon and clinical researcher whose contributions to emergency and critical care medicine are both extensive and impactful. His academic journey, clinical excellence, and substantial research output position him as a leader in trauma care in South Korea. Through his focused research on trauma mechanisms, surgical interventions, and critical care strategies, Dr. Choi has significantly advanced the understanding and management of severe trauma cases. His consistent participation in national and international trauma societies and his role in surgical education further highlight his influence within the medical community. Although his accomplishments are already remarkable, Dr. Choi has opportunities to expand his global collaborations, increase involvement in multicenter trials, and explore innovative technologies to further elevate his contributions to the field. His ability to balance clinical duties, research, and education is commendable and demonstrates his commitment to improving patient care and trauma system efficiency. Overall, Dr. Choi’s professional journey reflects a rare combination of surgical expertise, academic dedication, and passion for advancing trauma care, making him a deserving candidate for the Best Researcher Award.

Publications Top Notes

  • Differences in Characteristics of Trauma Between General Trauma and Suicidal Trauma–Trauma Mechanism, Injury Site, and Severity: A Single‐Center Study
    Ji Young Hyun, Yae Jun Son, SuHyun Kim, Keum Seok Bae, Jae Sik Chung, Il Hwan Park, Young Un Choi, Roberto Cirocchi
    2025

  • Mortality Trends in Chest-Abdominal Trauma Patients Before and After the Establishment of Trauma Centers in South Korea
    Dae Ryong Kang, Hye Sim Kim, Ji Young Jang, Ou-Hyen Kim, Kiyoung Kim, Un Young Choi, Jiwool Ko, Keum Seok Bae, Hongjin Shim
    2024

  • Occult Pneumothorax in Patients with Blunt Chest Trauma: Key Findings on Supine Chest Radiography
    Il Hwan Park, Chang Wan Kim, Young Un Choi, Tae Wook Kang, Jihye Lim, Chun Sung Byun
    2023

  • Association of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
    Young Un Choi, Chang Whan Kim, JiHye Lim, Il Hwan Park, Chun Sung Byun, Roberto Cirocchi
    2023

  • Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
    Jae Sik Chung, Myoung Jun Kim, Young Un Choi, Jun Gi Kim, Keum Seok Bae
    2023

  • Adjuvant Intravenous Immunoglobulin Administration on Postoperative Critically Ill Patients with Secondary Peritonitis: A Retrospective Study
    Young Un Choi, Jun Gi Kim, Ji Young Jang, Tae Hwa Go, Kwangmin Kim, Keum Seok Bae, Hongjin Shim
    2023

  • Outcomes Improvement Despite Continuous Visits of Severely Injured Patients During the COVID-19 Outbreak: Experience at a Regional Trauma Centre in South Korea
    Young Un Choi
    2022

  • Determination of Risk Factors for Predicting Bladder-Urethra Injury in Cases of Pelvic Bone Fracture: A Retrospective Single Center Study
    Ji Wool Ko, Myoung Jun Kim, Young Un Choi, Hongjin Shim, Hoejeong Chung, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

  • A Study on Trauma Mechanisms and Injury Sites in Patients with Blunt Abdominal Trauma
    YoungUn Choi, SuHyun Kim, JiWool Ko, MyoungJun Kim, Hongjin Shim, JaeHun Han, JiHye Lim, Kwangmin Kim, Roberto Cirocchi
    2022

  • Determination of Risk Factors Associated with Surgical Site Infection in Patients Undergoing Preperitoneal Pelvic Packing for Unstable Pelvic Fracture
    Kang Min Kim, Myoung Jun Kim, Jae Sik Chung, Ji Wool Ko, Young Un Choi, Hongjin Shim, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

Vanina Taliercio | Health Professions | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Vanina Taliercio | Health Professions | Best Researcher Award

Faculty, MD from University of Utah, United States

Dr. Vanina L. Taliercio is a physician-scientist whose career spans clinical practice, research, and academic leadership. Currently an Assistant Professor at the University of Utah, she brings extensive expertise in pediatrics, dermatology, genetics, and biomedical informatics. Her work integrates patient care with research, particularly focusing on genetic conditions, neurofibromatosis (NF), and tuberous sclerosis complex (TSC). Dr. Taliercio holds leadership roles as Co-director of both the NF and TSC clinics and serves as Associate Program Director for medical genetics and pediatrics/genetics programs. Her background includes significant contributions to national health initiatives, such as improving medication distribution systems for Hansen’s Disease in Argentina. In research, she has published several papers and presented at international conferences, particularly in dermatology and health informatics. Dr. Taliercio’s multidisciplinary approach, combining clinical insight with data-driven research, makes her a dynamic and impactful contributor to academic medicine. She is committed to advancing patient care, improving health outcomes, and mentoring the next generation of medical professionals.

Professional Profile

Education

Dr. Vanina Taliercio earned her Doctor of Medicine (MD) degree from Universidad del Salvador, Argentina, in 2002. To deepen her research expertise, she pursued a Master of Science (MS) in Biomedical Informatics at Oregon Health & Science University in 2012. Her postgraduate medical training is extensive and diverse. She completed a pediatrics residency at Pedro de Elizalde Hospital in Buenos Aires from 2003 to 2007, followed by a pediatric dermatology fellowship at Ramos Mejía Hospital from 2012 to 2015. After relocating to the United States, she undertook an ACGME residency in pediatrics at the University of Utah from 2020 to 2021, and most recently completed a medical genetics fellowship at the University of Utah between 2021 and 2023. This broad educational journey has equipped her with a unique combination of clinical and research expertise across multiple disciplines, positioning her well for leadership roles in academic medicine.

Professional Experience

Dr. Taliercio’s professional career spans several important roles in both Argentina and the United States. She began as a pediatrician at Hospital Italiano de Buenos Aires and OSDE, providing care to infants and children. She then worked as a clinical data research analyst, focusing on electronic health records, data reconciliation, and healthcare quality indicators, which led to key publications. At the national level, she contributed to Argentina’s Leprosy National Program, overseeing WHO medication distribution, developing national disease statistics, and creating educational materials to reduce stigma. Since moving to the United States, Dr. Taliercio has served as an Assistant Professor at the University of Utah, providing outpatient and inpatient care for patients with genetic and metabolic conditions. In addition, she co-directs two specialized clinics and supports the development of medical education programs as an Associate Program Director. Her career reflects a commitment to integrating clinical service, research, and academic leadership to improve patient care and healthcare systems.

Research Interests

Dr. Taliercio’s research interests span dermatology, genetics, pediatrics, and biomedical informatics. Her work has focused on psoriasis, alopecia, neurocutaneous disorders such as neurofibromatosis and tuberous sclerosis complex, and patient-reported outcomes. She is also interested in leveraging electronic health records and healthcare information systems to improve clinical decision-making and healthcare quality. Earlier in her career, she contributed to the development of mortality registries and national health databases, demonstrating a strong interest in population-level health outcomes and system-wide improvements. Her interdisciplinary approach combines clinical insights with data analysis, aiming to translate research findings into practical interventions that enhance patient care. She is particularly interested in collaborative, cross-disciplinary projects that bridge clinical practice with informatics tools and public health strategies.

Research Skills

Dr. Taliercio brings a broad set of research skills honed through years of clinical and academic work. She has expertise in clinical research design, data extraction and analysis from electronic health records, and the development of clinical research informatics tools. She has authored and co-authored several peer-reviewed publications and presented her work at national and international conferences. Dr. Taliercio has experience in conducting patient-reported outcomes research, implementing quality indicators in healthcare systems, and contributing to the development of national health guidelines. She also has teaching experience, having helped develop courses in clinical research and epidemiology. Her multidisciplinary training has given her strong analytical abilities, a deep understanding of clinical workflows, and the ability to bridge gaps between clinical practice and research. She is skilled at working collaboratively with clinicians, researchers, and informaticians to bring projects from concept to implementation.

Awards and Honors

While Dr. Taliercio’s profile highlights a range of accomplishments, formal details on specific research awards or honors are not explicitly listed. However, her leadership roles and appointments—such as Assistant Professor, Co-director of the NF and TSC clinics, and Associate Program Director—reflect strong recognition by her institution and peers. Additionally, her international career trajectory, moving from national public health leadership in Argentina to academic medicine in the United States, speaks to her professional reputation and the trust placed in her abilities. Her contributions to national guidelines on Hansen’s Disease in Argentina and her involvement in major research projects in dermatology and informatics show that she is regarded as a valuable collaborator and leader in her fields. Documenting formal research awards, grants, or recognitions in future applications would further strengthen this section.

Conclusion

In summary, Dr. Vanina Taliercio is a dedicated and accomplished physician-scientist who has made significant contributions across multiple disciplines, including dermatology, genetics, pediatrics, and biomedical informatics. Her career is marked by a unique combination of clinical service, research productivity, and academic leadership. She has consistently demonstrated a commitment to improving patient care, advancing medical knowledge, and mentoring students and trainees. While her profile would benefit from additional emphasis on independent research leadership and formal recognitions, she is clearly a rising figure in her field with the potential for even greater impact. Dr. Taliercio is a strong candidate for research-focused awards and honors, reflecting her broad expertise, international experience, and dedication to translational medicine. Continued pursuit of large-scale research projects, funding opportunities, and international collaborations will further enhance her academic and professional profile.

Publications Top Notes

  • Title: Worth the Effort: Lessons for Discovery and Care From an Unusual Case of Gorlin Syndrome
    Journal: American Journal of Medical Genetics Part A
    Date: 2025-05-03
    DOI: 10.1002/ajmg.a.64108
    Contributors: V. Taliercio; J. Zhao; S. E. Boyden; R. Mao; P. Bayrak‐Toydemir; A. Pflaum; J. Palumbos; A. Andrews; E. E. Baldwin; C. Welt et al.

  • Title: Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis
    Journal: International Journal of Behavioral Medicine
    Date: 2023-06
    DOI: 10.1007/s12529-022-10104-7
    Contributors: Ashley M. Snyder; Adelheid U. Brandenberger; Vanina L. Taliercio; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families
    Journal: JMIR Dermatology
    Date: 2021-10-04
    DOI: 10.2196/29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families (Preprint)
    Date: 2021-04-22
    DOI: 10.2196/preprints.29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

Xia Chen | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6

Fei Liu | Medicine and Dentistry | Young Scientist Award

Published on by Shen Awards

Dr. Fei Liu | Medicine and Dentistry | Young Scientist Award

FeiDr. Fei Liu is a dedicated and emerging researcher affiliated with The Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, China. His academic background is rooted in integrated traditional Chinese and Western medicine, with a research specialization in orthopedics. Dr. Liu has distinguished himself through his contributions to multiple research projects investigating the mechanisms of traditional Chinese medicine compounds and their therapeutic impact on orthopedic conditions. He is particularly focused on the pharmacological action of herbal formulas such as Duhuo Jisheng Tang, and their influence on pathways related to inflammation, apoptosis, and cellular metabolism. His scientific rigor is evident in his publication record, which includes six SCI-indexed journal articles (two as first author), and his involvement in several funded research grants at the provincial and municipal levels. Additionally, Dr. Liu holds a utility patent for an orthopedic surgical instrument, showcasing his commitment to clinical innovation. With a reputation for resilience, strong clinical foundations, and growing independent research capabilities, Dr. Liu is poised to make significant contributions to integrative medicine. Though early in his career, he has already demonstrated a promising trajectory, making him a strong candidate for emerging researcher recognition and a future contender for high-level scientific awards.

Professional Profile

Education

Dr. Fei Liu has pursued a comprehensive academic path in integrative medicine. He earned his undergraduate degree in Clinical Medicine of Integrated Traditional Chinese and Western Medicine from Hebei University of Chinese Medicine. This program laid a strong foundation in both conventional medical sciences and traditional Chinese therapeutic practices. Building upon this dual-focus education, he continued his studies at Southwest Medical University, where he undertook postgraduate training specializing in orthopedics within the same integrated clinical medicine discipline. His graduate research has centered on understanding the therapeutic mechanisms and efficacy of traditional herbal formulas used in orthopedic disorders. Dr. Liu’s educational experiences have provided him with a rare and valuable interdisciplinary skill set, enabling him to explore the complex biological interactions between traditional herbal compounds and modern biomedical systems. As a graduate student, he not only excelled academically—earning multiple prestigious scholarships—but also contributed actively to the academic community, serving as a student party committee member and engaging in various academic assistance roles. These educational milestones have shaped Dr. Liu into a well-rounded medical scientist with the tools to bridge traditional and modern medical practices effectively.

Professional Experience

Dr. Fei Liu’s professional journey has been primarily rooted in research and clinical training within the setting of Southwest Medical University and its affiliated hospital. During his postgraduate studies, he played significant roles in multiple ongoing research projects funded by the Sichuan Provincial Science and Technology Department, the Luzhou municipal government, and other institutional partnerships. He served as a second or third principal researcher on several studies investigating the pharmacological mechanisms of Duhuo Jisheng Tang and other herbal compounds in treating musculoskeletal disorders, particularly intervertebral disc degeneration. His work has involved both clinical observation and experimental design, contributing to tasks such as laboratory assay development, animal model experimentation, molecular analysis, and data interpretation. In parallel with his research activities, Dr. Liu has been involved in routine clinical work, managing patient admissions and performing basic surgical procedures such as internal fixation removals. His practical experience complements his scientific training, allowing him to integrate clinical insight with research innovation. Furthermore, he has actively participated in academic and administrative duties, serving within the student branch of the Party Committee and taking part in academic assistance programs. This balance of clinical proficiency and research engagement highlights his growing capacity as a clinician-scientist.

Research Interests

Dr. Fei Liu’s research interests lie at the intersection of traditional Chinese medicine (TCM) and modern biomedical science, with a particular focus on orthopedic applications. He is especially passionate about elucidating the pharmacological and molecular mechanisms underlying traditional herbal formulas, such as Duhuo Jisheng Tang, in the treatment of degenerative musculoskeletal conditions like intervertebral disc degeneration and osteoporosis. His projects have explored how these formulas influence biological pathways such as the JNK/P38MAPK signaling cascade, apoptosis (pyroptosis), glycolysis, and extracellular matrix degradation. Beyond musculoskeletal disorders, Dr. Liu has also contributed to interdisciplinary studies examining the immunological connections between COVID-19 and osteoporosis, and how m6A methylation affects prognosis and immunotherapy response in hepatocellular carcinoma. His holistic research approach integrates bioinformatics, in vivo and in vitro experimentation, and clinical data analysis. Dr. Liu is particularly interested in the potential of TCM to provide alternative therapeutic pathways with fewer side effects than synthetic drugs, especially when guided by modern research tools. His work contributes to the evolving field of integrative medicine, aiming to validate traditional knowledge using contemporary scientific methods and to promote evidence-based use of herbal treatments in modern clinical settings.

Research Skills

Dr. Fei Liu has developed a robust portfolio of research skills, well-suited to translational and interdisciplinary biomedical research. He possesses hands-on expertise in molecular biology techniques such as Western blotting, PCR, immunohistochemistry, and ELISA, which he has applied to study cellular signaling pathways in degenerative disc disease and related orthopedic conditions. In his various research projects, he has been actively involved in experimental design, animal modeling, data collection, statistical analysis, and manuscript preparation. Dr. Liu is also skilled in the use of bioinformatics tools for gene expression profiling and pathway analysis, which has allowed him to examine complex interactions between inflammation, immune response, and cellular metabolism. Additionally, he is familiar with biomechanical modeling, demonstrated by his collaborative work on lumbar spine simulations. His competence extends to academic writing, with several SCI-indexed journal publications, and to intellectual property development, as evidenced by his patent for a novel orthopedic surgical device. These combined skills reflect a balance of laboratory precision, analytical capability, and creative innovation. His ability to manage multiple research tasks while contributing meaningfully to both clinical and academic settings illustrates a strong foundation for continued scientific growth.

Awards and Honors

Throughout his academic career, Dr. Fei Liu has received several honors and recognitions that underscore his excellence in research and academic performance. He was awarded the National Second-Class Academic Scholarship for the 2020–2021 academic year and subsequently received the National First-Class Academic Scholarship for 2021–2022, highlighting his consistent academic distinction. In addition, he was honored with the “Kangzhe” Scholarship, a prestigious recognition of research potential in medical innovation. Dr. Liu has also been named an Outstanding Graduate Student of the 2020 cohort at his university, a distinction awarded to students demonstrating exceptional contributions in both research and leadership. His early commitment to scholarly excellence is further reflected in his participation as a student party committee member and his contributions to academic assistance initiatives. These accolades are not only a reflection of his academic abilities but also of his leadership qualities, dedication, and strong work ethic. They serve as indicators of his upward trajectory as a medical researcher and clinician. These honors reinforce his reputation as a promising young scholar, capable of making meaningful contributions to the field of integrative and orthopedic medicine.

Conclusion

In conclusion, Dr. Fei Liu exemplifies the qualities of a promising clinician-scientist whose work bridges traditional Chinese medicine and contemporary biomedical science. With a solid academic foundation, diverse professional experience, and a focused research agenda, he has contributed meaningfully to both experimental and translational studies. His involvement in several major research projects and his growing publication record demonstrate his potential for independent research leadership. Dr. Liu’s work not only advances understanding in the field of orthopedics but also enhances the scientific credibility of traditional medicine through rigorous investigation. He has already earned a patent, multiple scholarships, and recognitions that reflect his dedication and innovation. Although still in the early stages of his research career, he has established a strong foundation for future contributions at the national and international levels. With continued mentorship, expanded collaboration, and increased leadership in principal investigator roles, Dr. Liu is well-positioned to evolve into a leading figure in integrative medical research. His achievements to date make him a strong candidate for recognition in emerging researcher categories and a future contender for more senior scientific awards as his academic and professional journey progresses.

Publications Top Notes

Heba Jalloun | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Heba Jalloun | Medicine and Dentistry | Best Researcher Award

King Fahd Armed Forces Hospital from Saudi Arabia

Dr. Heba Essam Jalloun is a highly accomplished consultant in colorectal, minimally invasive, and robotic surgery, currently based at King Fahd Armed Forces Hospital (KFAFH) in Jeddah, Saudi Arabia. With over two decades of extensive clinical, academic, and research experience, Dr. Jalloun has demonstrated a steadfast commitment to the advancement of surgical practice, training, and innovation in her field. She earned her Bachelor’s degree in Medicine and Surgery from King Abdul-Aziz University in 2000, followed by the Saudi Specialty Certificate in General Surgery in 2008. Her international training includes two prestigious fellowships in South Korea focusing on minimally invasive, laparoscopic, robotic, oncology, and pelvic floor surgeries. Beyond her clinical responsibilities, she actively participates in training future surgeons as the Director of the General Surgery Saudi Board Residency Program at KFAFH. Dr. Jalloun is widely recognized for her contributions as a speaker at national and international conferences, as well as her active participation in surgical societies across Saudi Arabia, Europe, and Asia. Her work during the COVID-19 pandemic as a frontliner and her extensive involvement in global research collaborations further emphasize her dedication to both patient care and the academic community.

Professional Profile

Education

Dr. Heba Jalloun’s educational foundation is rooted in excellence and international exposure. She began her medical education at King Abdul-Aziz University, where she earned her Bachelor’s degree in Medicine and General Surgery (MBChB) between 1994 and 2000. After passing the Saudi License Exam in 2000, she pursued her residency in General Surgery through the Saudi Board program, completing her Saudi Specialty Certificate in General Surgery (SSC-SURG) in 2008. Her postgraduate training was distinguished by a strong focus on advanced surgical techniques, particularly in minimally invasive procedures. She furthered her expertise through two consecutive fellowships in South Korea: one in Minimal Invasive Surgery, Laparoscopic & Robotic Surgery for Colorectal Diseases (2015–2016), and the second in Oncology, Proctology, and Pelvic Floor Surgery (2017). These fellowships were undertaken at the Catholic University of Korea, Seoul St. Mary’s Hospital, providing her with global perspectives and high-level surgical training. Dr. Jalloun also acquired numerous certifications including ATLS instructor, Basic Surgical Skills instructor, Advanced Cardiac Life Support, and the Train of Trainer (TOT) program. Her dedication to continuous professional development is further evident through her involvement in structured surgical courses and certifications that support both clinical excellence and teaching proficiency.

Professional Experience

Dr. Heba Jalloun’s professional career spans over two decades of dedicated service, with a significant focus on general, colorectal, and robotic surgery. She began her journey in clinical practice as a resident in family medicine from 2001 to 2003, then transitioned into general surgery residency at Northwest Armed Forces Hospital and King Abdulaziz & Oncology Center from 2003 to 2008. After receiving her board certification, she was appointed as a Registrar and later an Assistant Consultant in General Surgery at KFAFH. Her expertise and leadership were recognized as she advanced to the roles of General Surgery Consultant in 2014 and Colorectal, Minimally Invasive, and Robotic Surgery Consultant in 2018. In 2022, she was appointed Director of the Saudi Board General Surgery Residency Program at KFAFH. Alongside clinical duties, Dr. Jalloun has led and organized numerous simulation-based training courses, contributed significantly to resident education, and participated in advanced surgical workshops both nationally and internationally. Her role during the COVID-19 pandemic as a frontliner and key investigator in global surgical research further highlights her dynamic and compassionate leadership. She is also an active member of surgical societies in Saudi Arabia and abroad, bridging international best practices with local healthcare advancements.

Research Interests

Dr. Heba Jalloun’s research interests are aligned closely with her clinical expertise in colorectal surgery, minimally invasive techniques, and oncology. She is deeply engaged in advancing surgical methodologies through evidence-based studies and is particularly focused on Enhanced Recovery After Surgery (ERAS) protocols, outcomes of laparoscopic procedures, and the management of colorectal diseases. Her international collaborations reflect her commitment to global health challenges, especially in the context of the COVID-19 pandemic, where she co-authored several high-impact publications addressing surgical delays, postoperative complications, and vaccine safety related to surgical outcomes. Additionally, she is interested in surgical education, clinical audits, and quality improvement projects—particularly those improving patient discharge efficiency and postoperative recovery. Dr. Jalloun has also explored surgical techniques in emergency abdominal procedures and rare case reports, including drug addiction among high school students. Her current and ongoing research includes hospital-based projects, international multicenter cohort studies, and case series publications. Through this multifaceted research approach, Dr. Jalloun aims to bridge gaps between clinical practice and academic inquiry, ultimately contributing to improved patient safety, surgical precision, and innovation in healthcare systems across the region and globally.

Research Skills

Dr. Heba Jalloun possesses a strong portfolio of research skills encompassing clinical study design, data collection, analysis, publication, and academic presentations. She has served as a principal investigator for several international multicenter studies focused on elective cancer surgery, acute cholecystitis, and surgical outcomes during the COVID-19 pandemic. Her contributions demonstrate proficiency in conducting prospective cohort studies, managing collaborative global datasets, and interpreting clinical implications across diverse healthcare settings. Additionally, Dr. Jalloun is skilled in writing and reviewing scientific manuscripts, poster presentations, and case reports. Her research on ERAS protocols, laparoscopic surgery outcomes, and oncologic safety has been published in respected international journals. She actively contributes to hospital-based quality improvement projects and is proficient in coordinating multidisciplinary research teams. Dr. Jalloun’s training experience also equips her with excellent skills in presenting at international symposiums, conducting workshops, and teaching evidence-based surgical practices. Her ability to integrate research into clinical practice makes her an asset to both academic and medical institutions. Furthermore, her dedication to mentorship and supervision of trainees in research-related tasks reinforces her role as a leader in academic medicine and clinical education.

Awards and Honors

Dr. Heba Jalloun has received multiple awards and honors in recognition of her clinical excellence, teaching capabilities, and service to the healthcare community. She was honored with the Best Instructor and Teacher award at King Fahd Armed Forces Hospital (KFAFH) for the academic year 2019–2020, reflecting her impactful contributions to surgical education. Earlier in her career, she was recognized as the Best Senior Registrar in 2010–2011, showcasing her exceptional performance during residency. Her role as an instructor in ATLS and Basic Surgical Skills courses since 2005 further highlights her longstanding commitment to surgical training. Dr. Jalloun received certificates of appreciation for her contributions to patient safety and experience in both 2021 and 2023, underlining her dedication to improving healthcare quality. During the COVID-19 pandemic, she was acknowledged for her invaluable service as a frontliner and key investigator in international research collaborations. Additionally, she has been commended for her participation as a speaker in numerous national and international symposiums. These accolades collectively reflect her multifaceted contributions as a surgeon, educator, researcher, and leader committed to advancing the field of surgery and patient care at both national and global levels.

Conclusion

In conclusion, Dr. Heba Essam Jalloun exemplifies the qualities of a distinguished surgeon, educator, and researcher, making her a strong candidate for the Best Researcher Award. Her career demonstrates an exceptional balance between clinical practice, academic leadership, and impactful research contributions. Through her international training in advanced surgical techniques and ongoing participation in global collaborative studies, she has significantly enriched both patient outcomes and medical knowledge. Her work during the COVID-19 pandemic, alongside her numerous publications and hospital projects, highlights her commitment to addressing real-world challenges with scientific rigor. Dr. Jalloun’s leadership in surgical education, evident from her role as Director of the Saudi Board Residency Program, further establishes her as a mentor and role model for future generations of surgeons. With multiple awards recognizing her teaching, service, and research, she has shown unwavering dedication to excellence in healthcare. While her work is already commendable, expanding her independent research leadership and engaging in broader interdisciplinary projects could further enhance her impact. Overall, Dr. Jalloun’s credentials and achievements reflect not only her expertise but also her vision for continuous innovation and improvement in surgery and medical education. She is a highly deserving candidate for this prestigious recognition.

Publications Top Notes

  • Title: Influence of the Enhanced Recovery After Surgery Protocol on Postoperative Inflammation and Short-Term Postoperative Surgical Outcomes After Colorectal Cancer Surgery

  • Authors: Jalloun Heba Essam (H.E.), Lee In Kyu (I.K.), Kim Min-ki (M.), Lee Yoon-suk (Y.), Jeon Hae-myung (H.)

  • Year: 2020

  • Citations: 19

Mrinalini Balki | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Mrinalini Balki | Medicine and Dentistry | Best Researcher Award

Professor from Mount Sinai Hospital, University of Toronto, Canada

Dr. Mrinalini Balki is a distinguished anesthesiologist and researcher specializing in obstetric anesthesia. With over two decades of experience in clinical practice and academia, she has significantly contributed to advancing maternal healthcare. She is a professor at the University of Toronto and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute. Dr. Balki’s research focuses on optimizing anesthetic techniques for labor and delivery, ensuring safer outcomes for mothers and newborns. Her extensive publication record and numerous national and international awards underscore her influence in the field. Throughout her career, she has combined clinical expertise with pioneering research, addressing critical challenges in anesthesia and obstetric care. She has also played a pivotal role in mentoring future anesthesiologists and researchers, fostering innovation and excellence. Recognized globally, her work has shaped the understanding of myometrial contractility, uterotonic agents, and anesthetic safety in obstetric patients. Her ongoing commitment to high-impact research, education, and clinical excellence positions her as a leading figure in her field. Dr. Balki’s dedication to improving patient safety, combined with her impressive research credentials, makes her a strong contender for the Best Researcher Award.

Professional Profile

Education

Dr. Balki has an extensive academic background in medicine and anesthesiology. She earned her Bachelor of Medicine and Bachelor of Surgery (MBBS) degree from Nagpur University, India, in 1994. She subsequently completed her Doctor of Medicine (MD) in Anesthesiology from Nagpur University in 1997, achieving specialist certification from the Maharashtra Medical Council. To further refine her expertise, she pursued multiple fellowships at the University of Toronto. From 2001 to 2004, she completed clinical and research fellowships in anesthesia, neuroanesthesia, and obstetric anesthesia at Toronto’s leading hospitals, including Mount Sinai Hospital, Toronto Western Hospital, and St. Michael’s Hospital. In addition to these achievements, Dr. Balki has obtained several professional certifications, including the Licentiate of the Medical Council of Canada (LMCC) in 2002 and certification in Neonatal Resuscitation in 2003. She has also successfully cleared the United States Medical Licensing Examination (USMLE) Step 1 & 2. Her continuous commitment to learning and updating her medical skills is further demonstrated by her Advanced Cardiac Life Support (ACLS) certification in 2025. Dr. Balki’s extensive education, combined with her postgraduate research training, has laid the foundation for her successful career in anesthesiology and research.

Professional Experience

Dr. Balki has an impressive professional background, spanning both clinical and academic roles. Since 2004, she has been an active staff member in the Department of Anesthesia at Mount Sinai Hospital, Toronto, where she provides expert anesthetic care, particularly in obstetric and perioperative anesthesia. She also holds clinical appointments at the Kensington Eye Institute and Women’s College Hospital. Academically, she has served at the University of Toronto for over two decades, progressing from Assistant Professor in 2004 to full Professor in 2021. She is a faculty member in the departments of Anesthesia, Obstetrics and Gynecology, and Physiology, reflecting her interdisciplinary expertise. Dr. Balki has also contributed to research as a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute since 2017. Her prior experience includes clinical appointments at the Centre for Addiction and Mental Health and University Health Network, further broadening her expertise. Internationally, she worked as a Staff Anesthesiologist in India before relocating to Canada. Her career reflects a strong combination of clinical excellence, academic leadership, and research innovation, making her a respected authority in the field of anesthesiology.

Research Interests

Dr. Balki’s primary research interest lies in obstetric anesthesia, particularly optimizing uterotonic drug administration and improving maternal outcomes. She has conducted extensive research on myometrial contractility, focusing on how various uterotonic agents interact with oxytocin to enhance or inhibit contractions during labor and postpartum hemorrhage treatment. Her work has significant implications for developing safer and more effective anesthesia protocols in obstetric care. Additionally, she is interested in maternal hemodynamics, pain management techniques during labor, and the effects of anesthetic drugs on both mother and fetus. Simulation-based medical education is another area of her research, aiming to improve interdisciplinary teamwork in obstetric crisis management. Her studies have influenced clinical guidelines and best practices in obstetric anesthesia. Dr. Balki is also involved in translational research, bridging the gap between laboratory findings and real-world clinical applications. Her interdisciplinary approach integrates pharmacology, anesthesiology, and obstetrics, ensuring a comprehensive understanding of maternal physiology and anesthetic response. Through her research, she continues to contribute to advancements in anesthesia safety, pain control, and maternal health outcomes.

Research Skills

Dr. Balki possesses a diverse set of research skills that have contributed to her success as a leading investigator in anesthesiology. She has expertise in designing and conducting randomized controlled trials, allowing her to generate high-quality clinical evidence. Her proficiency in in-vitro research methods has enabled her to explore myometrial contractility under various conditions, leading to innovative findings in obstetric pharmacology. She is skilled in advanced statistical analysis, ensuring data-driven decision-making in her research. Dr. Balki also excels in medical simulation-based research, using high-fidelity simulations to evaluate clinical teamwork and response to obstetric emergencies. She has experience in grant writing, securing significant funding for her studies. Additionally, her ability to collaborate with multidisciplinary teams, including anesthesiologists, obstetricians, and pharmacologists, has strengthened her research output. She is well-versed in systematic reviews and meta-analyses, allowing her to synthesize existing knowledge and identify research gaps. Her strong publication record, combined with her ability to translate research findings into clinical practice, demonstrates her exceptional research capabilities.

Awards and Honors

Dr. Balki has received numerous prestigious awards, reflecting her excellence in research and clinical practice. Internationally, she has been honored multiple times by the Society for Obstetric Anesthesia and Perinatology, receiving the esteemed Zuspan Award in 2006, 2009, 2010, and 2014. She has also won several Best Paper Awards, including at the Canadian Anesthesiologists’ Society Annual Meetings in 2008, 2009, 2011, 2012, 2016, and 2020. Her contributions to patient safety and medical education have been recognized with the Patient Safety Award and Research in Education Award in 2015. She was also awarded the Canadian Anesthesiologists’ Society Career Scientist Award and the Dr. R. A. Gordon Research Award. In addition to her received awards, she has been nominated multiple times for the Richard Knill Award, further affirming her impact on anesthesiology research. These recognitions highlight her consistent contributions to advancing knowledge and improving clinical practices in obstetric anesthesia.

Conclusion

Dr. Mrinalini Balki is a highly accomplished researcher whose work has made significant contributions to the field of anesthesiology, particularly in obstetric care. Her extensive research, spanning clinical trials and laboratory studies, has influenced maternal healthcare practices worldwide. Her leadership in academia, combined with her clinical expertise, has positioned her as a key figure in anesthesiology research. She has received multiple prestigious awards, reflecting her dedication to excellence and innovation. While her research primarily focuses on obstetric anesthesia, expanding collaborations in broader anesthesia fields and public health policy could further enhance her impact. Her exceptional research skills, commitment to education, and ability to translate findings into improved patient care make her a deserving candidate for the Best Researcher Award. Dr. Balki’s continued contributions to scientific advancements in anesthesia will undoubtedly shape the future of maternal and perioperative healthcare.

Publications Top Notes

  1. Title: Oxytocin versus carbetocin at elective Cesarean delivery in parturients with class III obesity: a double-blind randomized controlled noninferiority trial
    Authors: W. Turner, William; L. Boonstra, Linda; C.V. Maxwell, Cynthia V.; K.N. Downey, Kristi N.; M. Balki, Mrinalini
    Year: 2025

  2. Title: Maintenance infusion rate of oxytocin after initial 1-IU bolus for elective Cesarean delivery: a dose-finding study
    Authors: L. Boonstra, Linda; J.C.A. Carvalho, José Carlos Almeida; W. Turner, William; J.A. Thomas, Jackie A.; M. Balki, Mrinalini
    Year: 2024
    Citations: 1

  3. Title: Differential sensory block during labour epidural analgesia: a prospective observational study to investigate the relationship of lower and upper sensory block levels to cold, pinprick, and light touch
    Authors: J.F. Casellato, Julia F.; M. Balki, Mrinalini; A. Wang, Andrew; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida
    Year: 2024
    Citations: 4

  4. Title: In Response
    Authors: E. Peska, Emil; M. Balki, Mrinalini; W. Pfeifer, Wesla; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida

  5. Title: Oxytocin at Elective Cesarean Delivery: A Dose-Finding Study in Pregnant People with Twin Pregnancy
    Authors: E. Peska, Emil; M. Balki, Mrinalini; W. Pfeifer, Wesla; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida
    Year: 2024
    Citations: 4

  6. Title: Carbetocin vs. oxytocin at elective caesarean delivery: a reply
    Authors: M. Balki, Mrinalini; F. McDonagh, F.; J.C.A. Carvalho, José Carlos Almeida

  7. Title: In Response
    Authors: O.F.C. van den Bosch, Oscar F.C.; R.A. Chaudhry, Rabail Arif; J. Wicker, James; L. Munshi, Laveena; M. Balki, Mrinalini

  8. Title: Predictors and Hospital Outcomes in Pregnant Patients Undergoing Extracorporeal Membrane Oxygenation: A Nationwide Study
    Authors: O.F.C. van den Bosch, Oscar F.C.; R.A. Chaudhry, Rabail Arif; J. Wicker, James; L. Munshi, Laveena; M. Balki, Mrinalini
    Year: 2022
    Citations: 13

  9. Title: Association of body fluid distribution with obstructive sleep apnea in pregnant individuals with a body mass index ≥ 40 kg·m²—a prospective observational feasibility study
    Authors: J. Wicker, James; C.V. Maxwell, Cynthia V.; K.N. Downey, Kristi N.; M. Singh, Mandeep; M. Balki, Mrinalini

  10. Title: General anesthesia for Cesarean delivery in a parturient critically ill with COVID-19: a case report
    Authors: B. Kaminski, Bradley; W. Turner, William; M. Virdee, Misha; W.L. Whittle, Wendy L.; M. Balki, Mrinalini

 

Jonathan Super | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Mr. Jonathan Super | Medicine and Dentistry | Best Researcher Award

Royal Infirmary of Edinburgh, United Kingdom

Jonathan Thomas Matthew Super is a dedicated medical professional and researcher with expertise in trauma and orthopaedics. He holds an MBBS from Imperial College London and a First-Class Honours BSc in Exercise and Sport Sciences from Exeter University. With a strong clinical background and an impressive publication record, he has contributed extensively to orthopaedic research, focusing on biomechanics, surgical techniques, and healthcare inequalities. His work has been recognized through multiple commendations and awards, including the Wildcard Prize at the South East Scotland Orthopaedic Research Day. Jonathan’s ability to merge clinical practice with research has positioned him as a promising figure in the field of orthopaedics.

Professional Profile

Education

Jonathan Super completed his MBBS at Imperial College London between 2013 and 2020. During this time, he also pursued an intercalated BSc in Exercise and Sport Sciences at Exeter University, graduating with First-Class Honours in 2018. His early education at Solihull School was marked by academic excellence, earning 10 A*s at GCSE and A-levels in Chemistry, Biology, Mathematics, and Latin. He has further demonstrated his commitment to medical education by successfully passing the Intercollegiate MRCS examinations, solidifying his foundation in surgical sciences and clinical practice. His educational achievements reflect his dedication to both medicine and research.

Professional Experience

Jonathan’s clinical experience spans multiple specialties, with a primary focus on trauma and orthopaedics. Since August 2022, he has been undergoing Specialty Training in Trauma and Orthopaedics in the South East Scotland Rotation. Prior to this, he completed his Foundation Year training at Maidstone and Tunbridge Wells NHS Trust, gaining experience in orthogeriatric medicine, accident and emergency, otolaryngology, gastroenterology, general surgery, and liaison psychiatry. During the COVID-19 pandemic, he served as a volunteer and interim foundation doctor at St Mary’s Hospital, Paddington, showcasing his resilience and commitment to patient care. His diverse clinical background strengthens his ability to conduct research that is directly relevant to medical practice.

Research Interest

Jonathan’s research interests lie at the intersection of orthopaedic surgery, biomechanics, and healthcare disparities. He has explored topics such as biologic augmentation of meniscus repair, intra-articular injections for knee osteoarthritis, and survivorship outcomes in total ankle arthroplasty. Additionally, he has contributed to research on burnout in postgraduate trainees and the impact of socioeconomic status on medical training. His work highlights a commitment to improving both surgical techniques and the broader healthcare system. By addressing both clinical and systemic issues, Jonathan aims to advance the quality of patient care while also shaping medical education and policy.

Research Skills

Jonathan has developed a strong skill set in research methodologies, data analysis, and clinical trials. He is proficient in systematic reviews, retrospective cohort studies, and qualitative research. His ability to work with large datasets and analyze outcomes in orthopaedic surgery has led to multiple peer-reviewed publications. Additionally, he has experience in manuscript writing, grant applications, and conference presentations. His collaborative work with multidisciplinary teams further demonstrates his ability to contribute effectively to complex research projects. His research skills not only support his academic contributions but also ensure that his findings have practical applications in clinical practice.

Awards and Honors

Jonathan has received several academic and professional accolades throughout his career. At Imperial College London, he earned a Merit in Psychiatry, while his time at Exeter University was marked by a Dean’s Commendation and a Sport and Health Sciences Commendation for Academic Performance. His undergraduate research was recognized with the Human Kinetics Prize for Best Dissertation Poster. More recently, he was awarded the Wildcard Prize at the South East Scotland Orthopaedic Research Day in 2024. His achievements reflect both academic excellence and a commitment to advancing medical knowledge.

Conclusion

Jonathan Super has established himself as a dedicated clinician and researcher in the field of orthopaedics. His strong academic foundation, diverse clinical experience, and extensive research contributions position him as a promising candidate for prestigious scientific recognition. While he has already made significant strides in orthopaedic research, further leadership roles, independent research funding, and international collaborations would enhance his impact in the field. His commitment to advancing medical science and improving patient outcomes underscores his potential as a distinguished scientist.

Publications Top Notes

  • Title: 30-day morbidity and mortality of bariatric surgery during the COVID-19 pandemic: a multinational cohort study of 7704 patients from 42 countries
    Authors: R. Singhal, C. Ludwig, G. Rudge, G.V. Gkoutos, A. Tahrani, K. Mahawar, …
    Year: 2021
    Citations: 54

  • Title: 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data
    Authors: R. Singhal, V.R. Cardoso, T. Wiggins, J. Super, C. Ludwig, G.V. Gkoutos, …
    Year: 2022
    Citations: 46

  • Title: Waiting lists for symptomatic joint arthritis are not benign: prioritizing patients for surgery in the setting of COVID-19
    Authors: J.A. Morris, J. Super, D. Huntley, T. Ashdown, W. Harland, R. Anakwe
    Year: 2020
    Citations: 33

  • Title: Effect of COVID-19 pandemic on global bariatric surgery practices – The COBRAS study
    Authors: R. Singhal, A.A. Tahrani, N. Sakran, M. Herrera, V. Menon, M. Khaitan, …
    Year: 2021
    Citations: 27

  • Title: 30‐Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID‐19 pandemic – The GENEVA study
    Authors: R. Singhal, T. Wiggins, J. Super, A. Alqahtani, E.P. Nadler, C. Ludwig, …
    Year: 2021
    Citations: 18

  • Title: Current concepts in the management of bisphosphonate-associated atypical femoral fractures
    Authors: B. Rudran, J. Super, R. Jandoo, V. Babu, S. Nathan, E. Ibrahim, A.V. Wiik
    Year: 2021
    Citations: 16

  • Title: Open tibia/fibula in the elderly: a retrospective cohort study
    Authors: A. Lee, L. Geoghegan, G. Nolan, K. Cooper, J. Super, M. Pearse, S. Naique, …
    Year: 2022
    Citations: 15

  • Title: Triaging of respiratory protective equipment on the assumed risk of SARS-CoV-2 aerosol exposure in patient-facing healthcare workers delivering secondary care: a rapid review
    Authors: P. Ramaraj, J. Super, R. Doyle, C. Aylwin, S. Hettiaratchy
    Year: 2020
    Citations: 12

  • Title: FFP3 Feelings and Clinical Experience (FaCE). Facial pressure injuries in healthcare workers from FFP3 masks during the COVID-19 pandemic
    Authors: R.M. Kwasnicki, J.T. Super, P. Ramaraj, L. Savine, S.P. Hettiaratchy
    Year: 2022
    Citations: 11

  • Title: 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: A propensity score-matched analysis of the GENEVA data
    Authors: R. Singhal, V.R. Cardoso, T. Wiggins, J. Super, C. Ludwig, G.V. Gkoutos, …
    Year: 2022
    Citations: 7